Acutaas Chemicals Q4 FY26: Revenue up 40%, PAT up 114% YoY

Revenue Growth 20pctPat Growth 25pctEbitda Margin ExpansionResults View source PDF

ACUTAAS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+7.2%1-day move

₹2505.00

prior close

₹2523.70

base price

In-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0+0.1-0.1+6.2+7.2+6.6+7.1+9.2+9.6+10.2+17.9+20.3+41.2—

Up moveDown movePending

AI summary

Acutaas Chemicals reported strong Q4 & FY26 results. Q4 FY26 revenue grew 40.3% YoY to ₹4,328mn, PAT up 114.1% to ₹1,343mn (margin 31.0%). EBITDA margin surged to 42.4% from 27.5%. FY26 revenue rose 33% to ₹13,394mn; PAT jumped 122% to ₹3,564mn; EBITDA margin expanded to 35.9% from 23.0%. Management guided 25% revenue growth in FY27, citing battery chemicals, semiconductors, and pharma CDMO verticals.

Likely market impact

Strong beat across revenue, margins, and PAT signals robust growth and pricing power; positive outlook supports bullish sentiment.